Average Co-Inventor Count = 7.34
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amunix Operating Inc. (11 from 24 patents)
2. Amunix Pharmaceuticals, Inc (3 from 9 patents)
3. Bioverativ Therapeutics Inc. (1 from 71 patents)
4. Biogen Ma Inc. (250 patents)
15 patents:
1. 12071456 - Extended recombinant polypeptides and compositions comprising same
2. 10961287 - Extended recombinant polypeptides and compositions comprising same
3. 10870874 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
4. 10421798 - Factor VIII compositions and methods of making and using same
5. 9976166 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
6. 9926351 - Extended recombinant polypeptides and compositions comprising same
7. 9849188 - Growth hormone polypeptides and methods of making and using same
8. 9758776 - Coagulation factor IX compositions and methods of making and using same
9. 9376672 - Coagulation factor IX compositions and methods of making and using same
10. 9371369 - Extended recombinant polypeptides and compositions comprising same
11. 9249211 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
12. 9168312 - Growth hormone polypeptides and methods of making and using same
13. 9062299 - Coagulation factor IX compositions and methods of making and using same
14. 8716448 - Coagulation factor VII compositions and methods of making and using same
15. 8673860 - Extended recombinant polypeptides and compositions comprising same